These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9701379)

  • 1. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation.
    Ettinger AB; Weisbrot DM; Saracco J; Dhoon A; Kanner A; Devinsky O
    Epilepsia; 1998 Aug; 39(8):874-7. PubMed ID: 9701379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group.
    Brodie MJ; Yuen AW
    Epilepsy Res; 1997 Mar; 26(3):423-32. PubMed ID: 9127723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine.
    Beran RG; Gibson RJ
    Epilepsia; 1998 Mar; 39(3):280-2. PubMed ID: 9578045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 1996 Oct; 18(5):523-31. PubMed ID: 8885114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
    Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lamotrigine in add-on therapy: assessment of efficacy in drug resistant epilepsy].
    Juryńczyk J; Weglewski A
    Neurol Neurochir Pol; 2000; 34(1):43-7. PubMed ID: 10849903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
    Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
    Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.
    Chen B; Choi H; Hirsch LJ; Katz A; Legge A; Buchsbaum R; Detyniecki K
    Epilepsy Behav; 2017 Nov; 76():24-31. PubMed ID: 28931473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin.
    Steiner TJ; Dellaportas CI; Findley LJ; Gross M; Gibberd FB; Perkin GD; Park DM; Abbott R
    Epilepsia; 1999 May; 40(5):601-7. PubMed ID: 10386529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
    Gidal BE; Anderson GD; Rutecki PR; Shaw R; Lanning A
    Epilepsy Res; 2000 Nov; 42(1):23-31. PubMed ID: 10996503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure freedom with different therapeutic regimens in intellectually disabled epileptic patients.
    Huber B; Hauser I; Horstmann V; Jokeit G; Liem S; Meinert T; Robertson E; Schorlemmer H; Wagner W; Seidel M
    Seizure; 2005 Sep; 14(6):381-6. PubMed ID: 15985376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients.
    Yamamoto Y; Inoue Y; Matsuda K; Takahashi Y; Kagawa Y
    Biol Pharm Bull; 2012; 35(4):487-93. PubMed ID: 22466551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group.
    Faught E; Morris G; Jacobson M; French J; Harden C; Montouris G; Rosenfeld W
    Epilepsia; 1999 Aug; 40(8):1135-40. PubMed ID: 10448828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
    Hosford DA; Wang Y
    Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
    Brodie MJ; Wilson EA; Wesche DL; Alvey CW; Randinitis EJ; Posvar EL; Hounslow NJ; Bron NJ; Gibson GL; Bockbrader HN
    Epilepsia; 2005 Sep; 46(9):1407-13. PubMed ID: 16146435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.
    Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A
    Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE
    Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of lamotrigine on sleep in patients with epilepsy.
    Foldvary N; Perry M; Lee J; Dinner D; Morris HH
    Epilepsia; 2001 Dec; 42(12):1569-73. PubMed ID: 11879368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.